Lei Cao

Lei Cao

Auto-generated profile, based on publicly available information

Lei Cao

Orthopaedic Traumatology Trauma Center Shanghai General Hospital School of Medicine Shanghai Jiao Tong University Shanghai China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2024 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
YZYiqian Zhu
Yiqian Zhu
XLXuezhe Liu
Xuezhe Liu
KZKeyi Zhang
Keyi Zhang
MEMohamed El-Newehy
Mohamed El-Newehy
MAMeera Moydeen Abdulhameed
Meera Moydeen Abdulhameed
YWYongfei Wang
Yongfei Wang

16 December 2025 in JACS Au
Verified
Journal Article
Open access
CBChun Bi
Chun Bi
WFWen Fei
Wen Fei
HZHaoquan Zhang
Haoquan Zhang
JSJian Song
Jian Song
SCShixing Chen
Shixing Chen
LCLei Cao
Lei Cao
Wearable sweat sensors have emerged as promising tools for noninvasive health monitoring, yet the low analyte concentrations in sweat compared to blood pose significant challenges for the limit of detection. In this study, we developed a high-sensitivity electrochemical biosensor using carbon nanotube (CNT)-induced enzyme polymerization to detect uric acid and glucose with ultralow detection limits. The CNTs were functionalized via EDC/NHS to achieve covalent enzyme immobilization, enhancing catalytic efficiency, electron transfer, and sensor stability. To enable multifunctional sensing, we integrated glucose and uric acid detection with a pH sensor into a single wearable platform. A radially symmetric microfluidic module was designed through finite element analysis to optimize sweat flow and minimize refresh time, ensuring real-time biomarker tracking. The system also incorporated pH-based signal correction to improve detection accuracy in complex sweat environments. Finally, the sensing performance was validated through on-body sweat collection and analysis from six human volunteers, demonstrating its robustness, reliability, and potential for advancing next-generation personalized healthcare applications. This work provides a framework for designing multifunctional wearable sweat sensors and highlights the role of material and device innovations in overcoming key challenges in this field.

25 March 2026 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
LCLei Cao
Lei Cao
YMYan Mao
Yan Mao
CJChen-Xia Juan
Chen-Xia Juan
ZLZhi Long
Zhi Long
QWQian Wang
Qian Wang
Bronchopulmonary dysplasia (BPD) is a chronic lung disease primarily affecting preterm infants, characterised by impaired alveolar development and persistent inflammation, particularly associated with ventilator‐induced lung injury due to mechanical ventilation. In this study, we performed an integrated bioinformatic analysis of multiple datasets (GSE108754 and GSE39840) and identified 203 differentially expressed genes (DEGs) between BPD and control samples. Functional enrichment analysis revealed significant involvement in cytokine‐mediated signalling, response to lipopolysaccharide and regulation of interferon‐beta production. Using machine learning algorithms (LASSO, SVM‐RFE and Random Forest), we identified three hub genes (IL6, TFRC and PIEZO1) with high diagnostic accuracy for BPD. Immune infiltration analysis indicated altered immune cell proportions in BPD, with PIEZO1 expression positively correlated with neutrophil infiltration. Experimental validation confirmed elevated NETosis markers (PADI4, MPO, dsDNA) in BPD patients and further demonstrated that PIEZO1 overexpression promotes NET formation via calcium overload, which was inhibited by verapamil. Additionally, using a co‐culture system, we showed that PIEZO1‐induced NETosis exacerbates pulmonary fibrosis in lung epithelial cells. These findings highlight PIEZO1 as a key regulator of NETosis in BPD and a promising therapeutic target for mitigating lung injury and fibrosis.

11 June 2026 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
SWShiyang Weng
Shiyang Weng
KWKai Wu
Kai Wu
YHYinjun Huang
Yinjun Huang
LCLei Cao
Lei Cao
HFHuichao Fu
Huichao Fu
Objective: Spinal cord injury (SCI) is a severe secondary injury that often results in impaired motor function, imposing a significant burden on both individuals and society. Therefore, there is an urgent need for new therapeutic targets and strategies to address this challenge. Methods: To construct a mouse model of SCI, an aneurysm clip was used in vivo to clamp the abdominal aorta below the left renal artery in C57BL/6J mice. After 60 min, the aneurysm clip was removed to restore blood flow. In vitro, primary neuronal cells were subjected to OGD/R to mimic the conditions of SCI. Cell viability was assessed using the CCK‐8 assay, and the levels of neuronal death, autophagy, and ferroptosis were determined using a combination of WB, IF, and transmission electron microscopy. IP/MS and Co‐IP techniques were employed for the identification and validation of proteins interacting with USP5. Results: Neurons exhibit significant ferroptosis in the SCI mice. USP5 is markedly upregulated in SCI neurons and mediates neural ferroptosis. In vitro experiments demonstrate that overexpression of USP5 promotes neuronal ferroptosis, whereas knockout of USP5 significantly reduces it, with consistent results observed in vivo. Notably, the upregulation of USP5 expression markedly increases the accumulation of autophagosomes and autophagic flux in neurons, which may represent a potential mechanism by which USP5 mediates neuronal ferroptosis. Further investigations utilizing IP/MS and Co‐IP confirmed the interaction between USP5 and c‐MAF. Additionally, Western blot analysis revealed that USP5, through its deubiquitinating enzyme activity, enhances c‐MAF protein stability, thereby activating autophagy and subsequently promoting neuronal ferroptosis. Conclusion: In summary, our results indicate a close relationship between ferroptosis and SCI. USP5 regulates c‐MAF expression through deubiquitination, thereby activating autophagy‐dependent ferroptosis in neurons and mediating the progression of SCI. USP5 may serve as a potential therapeutic target for SCI.

6 October 2026 in Advanced Healthcare Materials
Verified
Journal Article
Open access
PDF file
PCPengfei Cai
Pengfei Cai
CLChunchun Li
Chunchun Li
CWChengqiang Wang
Chengqiang Wang
YDYangfan Ding
Yangfan Ding
JWJinglei Wu
Jinglei Wu
LSLiang Song
Liang Song
Incorporating nanofibers into 3D‐printed scaffolds is an effective strategy to enhance the physicochemical properties and osteogenic bioactivity of bone tissue engineering constructs. In this study, we developed a composite scaffold featuring a dual‐nanofiber interpenetrating network composed of silica (SiO 2 ) and poly(L‐lactic acid)/gelatin (PLLA/GEL) nanofibers. SiO 2 nanofibers were employed to reinforce mechanical properties and release bioactive Si elements, establishing a favorable osteogenic microenvironment. Concurrently, PLLA/GEL nanofibers were chemically crosslinked with the sodium alginate (SA) matrix to stabilize the scaffold structure. This design effectively addresses the structural instability often observed in single‐component inorganic fiber systems. Notably, systematic comparative experiments clarified the distinct contributions of each component. Results indicated that PLLA/GEL nanofibers primarily contributed to mechanical stability; however, their osteogenic contribution was not significantly superior to PLLA particles. In contrast, SiO 2 nanofibers exhibited superior bioactivity compared to nanoparticles in inducing osteogenic differentiation and promoting pro‐reparative macrophage polarization, leading to enhanced in vivo bone repair. This dual‐nanofiber network complementarily improves mechanical stability, modulates inflammation, and promotes osteogenic efficacy, offering a novel strategy for designing high‐performance functional bone tissue engineering scaffolds.